ADHD may intensify reproductive health challenges across menstruation, pregnancy, and menopause, new Irish cross-sectional data suggest.
The study compared 377 females with self-reported ADHD and 225 without ADHD, all living in Ireland and aged 18 to 69 years. Participants completed validated measures for ADHD symptoms, premenstrual symptoms, postpartum depression, and climacteric symptoms, with analysis focused on menstruation, perinatal health, and peri or postmenopausal experiences.
Females with ADHD reported significantly higher menstrual irregularity than those without ADHD. They also had more severe premenstrual symptoms across all domains of the Premenstrual Symptoms Screening Tool, including greater functional impact. Rates of premenstrual syndrome and premenstrual dysphoric disorder were significantly higher in the ADHD group, suggesting that menstrual health may be an important but underrecognized component of ADHD care.
Perinatal ADHD Risks
Perinatal findings also pointed to higher clinical vulnerability. Among participants who completed pregnancy related questions, females with ADHD had higher Edinburgh Postnatal Depression Scale scores and were more likely to meet the threshold for postpartum depression. The ADHD group also reported more unplanned pregnancies and more antenatal, perinatal, and postpartum complications, although there were no significant differences in age at first pregnancy, number of babies, miscarriage, stillbirth, or abortion.
The findings support closer attention to ADHD when assessing reproductive planning, pregnancy experience, and postpartum mental health. Executive function challenges linked to ADHD may affect contraception consistency and care navigation, while postpartum hormonal shifts may compound mood vulnerability.
ADHD And Menopause Symptoms
Among 218 participants in the peri or postmenopausal stage, climacteric symptom burden was significantly higher in the ADHD group. Total Greene Climacteric Scale scores, psychological symptoms, anxiety, depression, somatic symptoms, and sexual dysfunction scores were higher among females with ADHD, while vasomotor scores did not differ significantly between groups.
Hormone replacement therapy use was also higher in the ADHD group. This may reflect more severe menopausal symptoms, although overlapping ADHD and menopause symptoms could also complicate clinical interpretation.
ADHD symptom severity correlated with premenstrual, postpartum depression, and menopausal symptom severity across the sample. Because the study was cross-sectional and included self-reported ADHD, causality cannot be inferred. Still, the findings strengthen the case for lifespan-oriented, ADHD-informed care across female reproductive transitions.
Reference
Boyd C et al. ADHD and the female reproductive stages: menstruation, perinatal and menopause. Arch Womens Ment Health. 2026;29(3):89.
Featured Image: Svitlana on Adobe Stock.
